Detalhe da pesquisa
1.
Single-cell DNA-seq depicts clonal evolution of multiple driver alterations in osimertinib-resistant patients.
Ann Oncol;
33(4): 434-444, 2022 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35066105
2.
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.
Ann Oncol;
33(12): 1269-1283, 2022 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36089135
3.
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance.
Ann Oncol;
32(11): 1381-1390, 2021 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34416362
4.
Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer.
Ann Oncol;
29(suppl_1): i28-i37, 2018 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29462256
5.
Molecular mechanisms of acquired resistance to third-generation EGFR-TKIs in EGFR T790M-mutant lung cancer.
Ann Oncol;
30(5): 858, 2019 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29982319
6.
Precision medicine in the era of multi-omics: can the data tsunami guide rational treatment decision?
ESMO Open;
8(5): 101642, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37769400
7.
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer.
Oncogene;
32(47): 5377-87, 2013 Nov 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23934192